Categories
Latest Industry Intelligence
This latest ebook sponsored by Sino Biological features insight on how the global drug discovery and [...]
Cell therapy research has never been more exciting with all of the research ongoing. Download [...]
Orgenesis has agreed up to $50 million investment from Metalmark Capital in its US-based point of care services subsidiary, Morgenesis. The investment will consist of an upfront investment of $30 million and two future investments of $10 million each, subject to the achievement of certain milestones. Morgenesis will use the investment to develop and expand […]
Menu ≡ ╳ 
